COPD Co-morbidites, CVD and metabolic diseases

PheWeb

COPD_CVDMETABOCOMORB

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries None

Check pre-conditions, main-only, mode, ICD version None

Check minimum number of events None

Include endpoints

I9_ISCHHEART

I9_CEREBVASC

I9_SECONDRIGHT

CARDIAC_ARRHYTM

E4_DIABETES

122323

COPD_CVDMETABOCOMORB

Extra metadata

First used in FinnGen datafreeze DF2

Similar endpoints

↥

List of similar endpoints to COPD Co-morbidites, CVD and metabolic diseases based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	118527	53474	65053
Unadjusted prevalence (%)	38.41	30.82	48.18
Mean age at first event (years)	56.94	55.89	57.79

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.04	4.59 [4.30, 4.91]	<1e-100	20443
15 years	0.01	3.08 [2.86, 3.32]	<1e-100	9244
5 years	0.00	4.54 [4.17, 4.95]	<1e-100	4288
1 year	0.00	20.46 [17.64, 23.73]	<1e-100	3567

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: COPD_CVDMETABOCOMORB – COPD Co-morbidites, CVD and metabolic diseases
GWS hits:

Survival analyses between endpoints

↥

Plot

before COPD Co-morbidites, CVD and metabolic diseases
after COPD Co-morbidites, CVD and metabolic diseases

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after COPD Co-morbidites, CVD and metabolic diseases

↥